Moderna to purchase and invest more than $320M in MA biomanufacturing site
mRNA vaccine leader Moderna will be expanding its manufacturing apparatus not far from its home in Cambridge, MA.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
